Join the 200th Anniversary Celebration

Correspondence

Human Granulocytic Ehrlichiosis in Western Europe

N Engl J Med 1999; 340:1214-1216April 15, 1999

Article

To the Editor:

Human granulocytic ehrlichiosis was first reported in the United States in 1994.1 Over the past five years at least several hundred cases have been reported, mostly in the upper Midwest and Northeast, regions where other diseases transmitted by Ixodes scapularis ticks, such as Lyme disease and babesiosis, are common. Four cases of human granulocytic ehrlichiosis have also recently been documented in Slovenia.2 We describe a case of human granulocytic ehrlichiosis in western Europe.

In September 1998, a 58-year-old Dutch man presented with a seven-day history of fever, chills, and diarrhea. He often camped in Gelderland, a region where Lyme disease is prevalent; however, a recent tick bite was not noted. He had not been out of the Netherlands during the six months before his illness. On examination, the temperature was 39.8°C and several petechiae were noted on the legs. Laboratory testing demonstrated leukopenia (3400 leukocytes per cubic millimeter) and thrombocytopenia (24,000 platelets per cubic millimeter). Levels of creatine kinase (1460 U per liter), aspartate aminotransferase (516 U per liter), alanine aminotransferase (208 U per liter), and lactate dehydrogenase (2970 U per liter) were elevated. Examination of a peripheral-blood smear revealed characteristic morulae containing the agent of human granulocytic ehrlichiosis in 7 percent of the polymorphonuclear leukocytes (Figure 1AFigure 1Diagnosis of Human Granulocytic Ehrlichiosis.). The patient was treated with 200 mg of doxycycline orally per day for two weeks, and his symptoms resolved within a few days.

The results of serologic and polymerase-chain-reaction (PCR) tests further supported the diagnosis of human granulocytic ehrlichiosis. An indirect immunofluorescence (IgG) assay in which HL-60 cells infected with human granulocytic ehrlichiosis were used as the antigen3 was initially negative and then became positive (serum dilution, up to 1:1000) at four weeks (Figure 1B). IgG antibodies to recombinant HGE-44, a 44-kd protein commonly recognized in cases of human granulocytic ehrlichiosis in the United States,4 were readily detected on immunoblotting at four weeks, at a serum dilution of up to 1:12,000 (Figure 1C). Neither the immunofluorescence assay nor immunoblotting detected IgM antibodies at either time. Human granulocytic ehrlichiosis DNA was detected by PCR with HGE-44 primers in peripheral blood obtained from the patient at presentation.4,5 Sequencing of 150 bp at the 5' region of the amplified HGE-44 DNA revealed 96 percent homology with the HGE-44 gene from an organism isolated in Massachusetts.4

These data demonstrate that human granulocytic ehrlichiosis occurs in western Europe and should be considered in the differential diagnosis when evaluating persons who are at risk for tick-borne diseases. Antibodies to HGE-44 develop during infection, and the identification of these antibodies may aid in the diagnosis of the disease in both the United States and Europe. As human granulocytic ehrlichiosis becomes more commonly recognized on various continents, the ecology and epidemiology of this emerging infection and the spectrum of clinical disease should become more completely understood.

Aart van Dobbenburgh, M.D.
Het Spittaal Hospital, 7207 BA Zutphen, the Netherlands

Alje P. van Dam, M.D., Ph.D.
University of Amsterdam, 1100 DE Amsterdam, the Netherlands

Erol Fikrig, M.D.
Yale University School of Medicine, New Haven, CT 06520-8031

5 References
  1. 1

    Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589-595
    Web of Science | Medline

  2. 2

    Lotric-Furlan S, Perovec M, Zupanc TA, et al. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 1998;27:424-428
    CrossRef | Web of Science | Medline

  3. 3

    Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-215[Erratum, N Engl J Med 1996;335:361.]
    Full Text | Web of Science | Medline

  4. 4

    Ijdo JW, Sun W, Zhang Y, Magnarelli LA, Fikrig E. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun 1998;66:3264-3269
    Web of Science | Medline

  5. 5

    Magnarelli LA, Ijdo JW, Stafford KC, Fikrig E. Infections of granulocytic ehrlichia and Borrelia burgdorferi in white-tailed deer in Connecticut. J Wild Dis (in press).

Citing Articles (26)

Citing Articles

  1. 1

    Christelle Koebel, Aurélie Kern, Sophie Edouard, Anh Thu Hoang, Noéline Celestin, Yves Hansmann, Benoît Jaulhac, Philippe Brouqui, Sylvie Josiane De Martino. (2012) Human granulocytic anaplasmosis in eastern France: clinical presentation and laboratory diagnosis. Diagnostic Microbiology and Infectious Disease 72:3, 214-218
    CrossRef

  2. 2

    Hongtao Jin, Feng Wei, Quan Liu, Jun Qian. (2012) Epidemiology and Control of Human Granulocytic Anaplasmosis: A Systematic Review. Vector-Borne and Zoonotic Diseases120104061731004
    CrossRef

  3. 3

    Christel Cochez, Geneviève Ducoffre, Christian Vandenvelde, Victor Luyasu, Paul Heyman. (2011) Human anaplasmosis in Belgium: A 10-year seroepidemiological study. Ticks and Tick-borne Diseases 2:3, 156-159
    CrossRef

  4. 4

    Ellen Tijsse-Klasen, Jac J Jacobs, Arno Swart, Manoj Fonville, Johan H Reimerink, Afke H Brandenburg, Joke WB van der Giessen, Agnetha Hofhuis, Hein Sprong. (2011) Small risk of developing symptomatic tick-borne diseases following a tick bite in the Netherlands. Parasites & Vectors 4:1, 17
    CrossRef

  5. 5

    Elisabeth Haschke-Becher, Rainer Bernauer, Anna-Maria Walleczek, Petra Apfalter, Shahrzad Afazel-Saeedi, Joerg Kraus, Gunther Ladurner, Peter Strasser. (2010) First detection of the Anaplasma phagocytophilum groEL-A genotype in man. Journal of Infection 60:4, 300-305
    CrossRef

  6. 6

    Ursula Maria Vogl, Elisabeth Presterl, Gerold Stanek, Michael Ramharter, Klaus-Bernhard Gattringer, Wolfgang Graninger. (2010) First described case of human granulocytic anaplasmosis in a patient in Eastern Austria. Wiener Medizinische Wochenschrift 160:3-4, 91-93
    CrossRef

  7. 7

    Zerai Woldehiwet. (2010) The natural history of Anaplasma phagocytophilum. Veterinary Parasitology 167:2-4, 108-122
    CrossRef

  8. 8

    Paul Heyman, Christel Cochez, Agnetha Hofhuis, Joke van der Giessen, Hein Sprong, Sarah Rebecca Porter, Bertrand Losson, Claude Saegerman, Oliver Donoso-Mantke, Matthias Niedrig, Anna Papa. (2010) A clear and present danger: tick-borne diseases in Europe. Expert Review of Anti-infective Therapy 8:1, 33-50
    CrossRef

  9. 9

    Rachael J Thomas, J Stephen Dumler, Jason A Carlyon. (2009) Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Review of Anti-infective Therapy 7:6, 709-722
    CrossRef

  10. 10

    Kathrin Hartelt, Silvia Pluta, Rainer Oehme, Peter Kimmig. (2008) Spread of ticks and tick-borne diseases in Germany due to global warming. Parasitology Research 103:S1, 109-116
    CrossRef

  11. 11

    Florence Fenollar, Pierre-Edouard Fournier, Didier Raoult. 2007. Diagnostic Strategy of Rickettsioses and Ehrlichioses. , 315-330.
    CrossRef

  12. 12

    Stanka Lotrič-Furlan, Tereza Rojko, Miroslav Petrovec, Tatjana Avšič-Županc, Franc Strle. (2006) Epidemiological, clinical and laboratory characteristics of patients with human granulocytic anaplasmosis in Slovenia. Wiener klinische Wochenschrift 118:21-22, 708-713
    CrossRef

  13. 13

    EUGENIO LILLINI, GLADIA MACRÌ, GABRIELLA PROIETTI, MANUELA SCARPULLA. (2006) New Findings on Anaplasmosis Caused by Infection with Anaplasma phagocytophilum. Annals of the New York Academy of Sciences 1081:1, 360-370
    CrossRef

  14. 14

    Constance A. Bell, Robin Patel. (2005) A real-time combined polymerase chain reaction assay for the rapid detection and differentiation of Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Ehrlichia ewingii. Diagnostic Microbiology and Infectious Disease 53:4, 301-306
    CrossRef

  15. 15

    P. Brouqui, F. Bacellar, G. Baranton, R. J. Birtles, A. Bjoersdorff, J. R. Blanco, G. Caruso, M. Cinco, P. E. Fournier, E. Francavilla, M. Jensenius, J. Kazar, H. Laferl, A. Lakos, S. Lotric Furlan, M. Maurin, J. A. Oteo, P. Parola, C. Perez-Eid, O. Peter, D. Postic, D. Raoult, A. Tellez, Y. Tselentis, B. Wilske. (2004) Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clinical Microbiology and Infection 10:12, 1108-1132
    CrossRef

  16. 16

    Philippe Parola. (2004) Tick-borne rickettsial diseases: emerging risks in Europe. Comparative Immunology, Microbiology and Infectious Diseases 27:5, 297-304
    CrossRef

  17. 17

    V. Remy, Y. Hansmann, S. De Martino, D. Christmann, P. Brouqui. (2003) Human Anaplasmosis Presenting as Atypical Pneumonitis in France. Clinical Infectious Diseases 37:6, 846-848
    CrossRef

  18. 18

    JOHANNA MAKINEN, ILPPO VUORINEN, JARMO OKSI, MIIKKA PELTOMAA, QIUSHUI HE, MERJA MARJAMAKI, MATTI K. VILJANEN. (2003) Prevalence of granulocytic Ehrlichia and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected from Southwestern Finland and from Vormsi Island in Estonia. APMIS 111:2, 355-362
    CrossRef

  19. 19

    J. R. Blanco, J. A. Oteo. (2002) Human granulocytic ehrlichiosis in Europe. Clinical Microbiology and Infection 8:12, 763-772
    CrossRef

  20. 20

    Petr Zeman, Petr Pazdiora, Jaroslav Cinatl. (2002) HGE antibodies in sera of patients with TBE in the Czech Republic. International Journal of Medical Microbiology 291, 190-193
    CrossRef

  21. 21

    Rainer Oehme, Kathrin Hartelt, Hannelore Backe, Stefan Brockmann, Peter Kimmig. (2002) Foci of tick-borne diseases in Southwest Germany. International Journal of Medical Microbiology 291, 22-29
    CrossRef

  22. 22

    Charles Thompson, Andrew Spielman, Peter J. Krause. (2001) Coinfecting Deer‐Associated Zoonoses: Lyme Disease, Babesiosis, and Ehrlichiosis. Clinical Infectious Diseases 33:5, 676-685
    CrossRef

  23. 23

    Jana Hercogova, Iva Brzonova. (2001) Lyme disease in central Europe. Current Opinion in Infectious Diseases 14:2, 133-137
    CrossRef

  24. 24

    P. Parola, D. Raoult. (2001) Ticks and Tickborne Bacterial Diseases in Humans: An Emerging Infectious Threat. Clinical Infectious Diseases 32:6, 897-928
    CrossRef

  25. 25

    P. Parola, D. Raoult. (2001) Tick-borne bacterial diseases emerging in Europe. Clinical Microbiology and Infection 7:2, 80-83
    CrossRef

  26. 26

    J. S. Bakken, J. S. Dumler. (2000) Human Granulocytic Ehrlichiosis. Clinical Infectious Diseases 31:2, 554-560
    CrossRef